Replies to post #229930 on Amarin Corp Plc (AMRN)

[KCSVEN]

Those peak sales would be numbers MDCO would throw out there, based on competitors and iffy outcome trial results Bp should have been modeling 1.5 billion peak. Based on your logic Amarin should be bought based on 10 billion peak sales. This is an overpay which is worse than 50/50 to pay back much in cash flow over the life of the drug.